Acceligen
the first FDA low-risk clearance for a gene-edited cattle line, covering two heat-tolerant lines and their offspring.
- Country
- United States
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdacfiamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Livestock genetic engineering and precision breeding | livestock-aqua | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.